ASSERTIO
Assertio is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other central nervous system conditions. The company was founded in 1995 and has established itself by developing and incorporating promising technology into differentiated therapeutic products, taking those products through clinical approval, and building a strong market presence. The company currently markets four FDA-approved products, Gralise (gabapentin) tablets for the manage... ment of Postherpetic Neuralgia (PHN), Cambia (diclofenac potassium for oral solution) for the acute treatment of migraine attacks with or without aura in adults 18 years of age or older, Zipsor (diclofenac potassium) liquid-filled capsules for relief of mild to moderate acute pain, and Lazanda (fentanyl) nasal spray CII for the management of breakthrough pain in cancer patients. See Important Safety Information for Gralise, Cambia, Zipsor, and Lazanda.
ASSERTIO
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics Life Science Medical Pharmaceutical
Founded:
1995-01-01
Address:
Lake Forest, Illinois, United States
Country:
United States
Website Url:
http://www.assertiotx.com
Total Employee:
101+
Status:
Active
Contact:
224.419.7106
Email Addresses:
[email protected]
Total Funding:
1.01 B USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network
Similar Organizations
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
BioDelivery Sciences
BioDelivery Sciences is a pharmaceutical company that focuses on pain management and addiction medicine.
Peplin
Peplin is a specialty pharmaceutical company focused on advancing and commercializing medical dermatology products.
Current Advisors List
Current Employees Featured
Stock Details
Investors List
Deerfield
Deerfield investment in Post-IPO Debt - Assertio
Pharmakon Advisors
Pharmakon Advisors investment in Post-IPO Debt - Assertio
Morgan Stanley
Morgan Stanley investment in Post-IPO Debt - Assertio
RBC Capital Markets
RBC Capital Markets investment in Post-IPO Debt - Assertio
Thomas Weisel Partners
Thomas Weisel Partners investment in Post-IPO Equity - Assertio
Official Site Inspections
http://www.assertiotx.com Semrush global rank: 2.13 M Semrush visits lastest month: 9.48 K
Unable to get host informations!!!